Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

4.85
Delayed Data
As of Dec 11
 +0.125 / +2.65%
Today’s Change
2.25
Today|||52-Week Range
6.30
+61.67%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close4.72
Today’s open4.70
Day’s range4.50 - 4.87
Volume369,458
Average volume (3 months)691,606
Market cap$155.1M
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+48.73%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...+0.09+1.71%
TRVNTrevena Inc+0.16+10.53%
REPHRecro Pharma Inc+0.17+1.76%
MDWDMediwound Ltd+0.15+3.30%
Data as of 4:00pm ET, 12/11/2017

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts